In that same month, recreational cannabis sales in Arizona totaled $73.8 million, which was a new high. In October, medical marijuana sales in the state amounted to a little more than $31 million, which was the eighth consecutive month of decline. A bill that would expand the list of qualifying conditions for medical cannabis and lower the cost of the treatment was approved by lawmakers in Arizona. The medical market has continued to bleed both sales and participants, following a trend in some states that have legalized adult-use cannabis years after establishing medical cannabis markets.” If it were to become law, the measure would result in a host of changes to the state’s medical cannabis law––perhaps most notably, the addition of autism and post-traumatic stress disorder to the list of qualifying conditions.
A bill that would expand the list of qualifying conditions for medical cannabis and lower the cost of the treatment was approved by lawmakers in Arizona.
The bill, SB 1466, was approved on Monday by a legislative committee. If it were to become law, the measure would result in a host of changes to the state’s medical cannabis law––perhaps most notably, the addition of autism and post-traumatic stress disorder to the list of qualifying conditions.
It was approved by a 7-2 vote by members of the Health and Human Services Committee Hearing.
Read the full article @ High Times